The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2025

Filed:

Jun. 21, 2021
Applicant:

Neurofluidics, Inc., St. Paul, MN (US);

Inventors:

Shivanand Lad, Durham, NC (US);

William C. Mobley, La Jolla, CA (US);

Karoly Nikolich, Emerald Hill, CA (US);

Thomas Saul, El Granada, CA (US);

Assignee:

NEUROFLUIDICS, INC., St. Paul, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 27/00 (2005.12); A61M 25/00 (2005.12); A61M 1/36 (2005.12);
U.S. Cl.
CPC ...
A61M 27/006 (2012.12); A61M 25/0026 (2012.12); A61M 1/3679 (2012.12); A61M 2025/0007 (2012.12); A61M 2027/004 (2012.12); A61M 2202/0021 (2012.12); A61M 2202/0464 (2012.12); A61M 2202/203 (2012.12); A61M 2202/206 (2012.12); A61M 2206/16 (2012.12); A61M 2210/0693 (2012.12); A61M 2210/1003 (2012.12);
Abstract

The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. The systems provide for a catheter flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.


Find Patent Forward Citations

Loading…